HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Malone, R. E Search for Related Content PubMed PubMed Citation Articles by Malone, R. E

Working to make a disease

Correspondence to:
Ruth E Malone, RN, PhD, Professor and Vice Chair, Department of Social & Behavioral Sciences, University of California, San Francisco, 3333 California Street, Suite 455, San Francisco, CA 94118, USA; ruth.malone@ucsf.edu

Keywords: Philip Morris; corporate social responsibility; tobacco industry

The first 150 words of the full text of this article appear below.

Three years ago, I attended a public talk at the University of California, Berkeley School of Business. The topic was corporate social responsibility, and the speaker was David Greenberg, senior vice-president and chief compliance officer at Altria, parent corporation of tobacco giant Philip Morris. Greenberg was a smiling, somewhat self effacing guy about my own age, and he began his talk by saying how he appreciated our willingness to listen, because he wanted to tell us some things about his company that "might surprise" us.

Greenberg said the organisation had recently done a lot of soul searching and realised it needed to change—there was a new "openness" in "Altria’s journey," as Greenberg put it, in which the organisation had "outed ourselves." He alluded to "almost religious" battles within the corporation about the "new" stance of "responsibility," as part of which Altria/Philip Morris finally admits (on . . . [Full text of this article]